NeoGenomics (NEO) News Today $11.10 -0.76 (-6.41%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$11.03 -0.07 (-0.63%) As of 02/21/2025 07:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Leerink Partnrs Increases Earnings Estimates for NeoGenomicsFebruary 22 at 2:26 AM | americanbankingnews.comBank of America Issues Pessimistic Forecast for NeoGenomics (NASDAQ:NEO) Stock PriceBank of America decreased their price target on NeoGenomics from $19.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday.February 20 at 8:24 AM | marketbeat.comNeoGenomics (NASDAQ:NEO) Price Target Cut to $18.00 by Analysts at Needham & Company LLCNeedham & Company LLC dropped their target price on NeoGenomics from $19.00 to $18.00 and set a "buy" rating on the stock in a report on Wednesday.February 20 at 8:05 AM | marketbeat.comNeoGenomics price target lowered to $17 from $18 at BTIGFebruary 20 at 7:33 AM | markets.businessinsider.comNeoGenomics price target lowered to $16 from $19 at BofAFebruary 20 at 2:29 AM | markets.businessinsider.comFort Myers-based NeoGenomics reports mixed results for the fourth quarterFebruary 20 at 2:29 AM | msn.comNeoGenomics (NASDAQ:NEO) Sets New 1-Year Low on Disappointing EarningsFebruary 20 at 1:19 AM | americanbankingnews.comNeoGenomics price target lowered to $19 from $20 at TD CowenFebruary 19 at 10:40 AM | markets.businessinsider.comNeoGenomics (NASDAQ:NEO) Sets New 52-Week Low After Earnings MissNeoGenomics (NASDAQ:NEO) Hits New 52-Week Low After Earnings MissFebruary 19 at 10:22 AM | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Q4 2024 Earnings Call TranscriptFebruary 19 at 9:20 AM | insidermonkey.comNeoGenomics (NASDAQ:NEO) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPSNeoGenomics (NASDAQ:NEO - Get Free Report) issued its quarterly earnings data on Tuesday. The medical research company reported ($0.02) earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.05). NeoGenomics had a negative return on equity of 2.11% and a negative net margin of 12.07%.February 19 at 8:15 AM | marketbeat.comNeoGenomics (NASDAQ:NEO) Issues Earnings ResultsNeoGenomics (NASDAQ:NEO - Get Free Report) announced its quarterly earnings data on Tuesday. The medical research company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by ($0.05). NeoGenomics had a negative net margin of 12.07% and a negative return on equity of 2.11%.February 19 at 7:57 AM | marketbeat.comNeoGenomics stock tumbles on weak EPS guidanceFebruary 19 at 12:38 AM | investing.comNeoGenomics reports Q4 adjusted EPS 4c, consensus 3cFebruary 19 at 12:38 AM | markets.businessinsider.comNeoGenomics Shares Decline on Forecast for Wider-Than-Expected Loss in 2025February 19 at 12:38 AM | marketwatch.comNeoGenomics targets 1M patients annually by 2028 with 11%-13% revenue growth in 2025February 19 at 12:38 AM | msn.comWhy NeoGenomics (NEO) Shares Are Trading Lower TodayFebruary 19 at 12:38 AM | msn.comNeoGenomics (NASDAQ:NEO) Misses Q4 Sales TargetsFebruary 19 at 12:38 AM | finance.yahoo.comNeoGenomics, Inc (NEO) Q4 2024 Earnings Call TranscriptFebruary 18, 2025 | seekingalpha.comNeoGenomics, Inc. 2024 Q4 - Results - Earnings Call PresentationFebruary 18, 2025 | seekingalpha.comNeoGenomics Reports Fourth Quarter and Full Year 2024 ResultsFebruary 18, 2025 | finance.yahoo.comNeoGenomics (NEO) To Report Earnings Tomorrow: Here Is What To ExpectFebruary 17, 2025 | msn.comNeoGenomics (NEO) Receives a Buy from Craig-HallumFebruary 13, 2025 | markets.businessinsider.comNeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of "Moderate Buy" by AnalystsShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eleven research firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and nine have given a buy raFebruary 13, 2025 | marketbeat.comNeoGenomics (NEO) to Release Quarterly Earnings on TuesdayNeoGenomics (NASDAQ:NEO) will be releasing earnings before the market opens on Tuesday, February 18, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=660267)February 11, 2025 | marketbeat.comNEO Battery Materials Scaling-Up Production to 20 Tons Per Year for Mass-Producibility TestingFebruary 6, 2025 | globenewswire.comJennison Associates LLC Purchases 238,288 Shares of NeoGenomics, Inc. (NASDAQ:NEO)Jennison Associates LLC grew its holdings in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 18.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,514,756 shares of the medical research coFebruary 6, 2025 | marketbeat.com32,030 Shares in NeoGenomics, Inc. (NASDAQ:NEO) Acquired by Guidance Capital Inc.Guidance Capital Inc. purchased a new position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 32,030 shares of the medical research compFebruary 5, 2025 | marketbeat.comOak Family Advisors LLC Trims Position in NeoGenomics, Inc. (NASDAQ:NEO)Oak Family Advisors LLC trimmed its position in NeoGenomics, Inc. (NASDAQ:NEO - Free Report) by 87.4% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,612 shares of the medical research company's stock after selling 94,350 shares during the periodFebruary 3, 2025 | marketbeat.comThe big haulJanuary 31, 2025 | ft.comPacBio appoints Smith to board of directorsJanuary 31, 2025 | markets.businessinsider.comMenlo Park-based biotech company welcomes Florida exec to boardJanuary 31, 2025 | bizjournals.comPacBio adds NeoGenomics CEO to its boardJanuary 31, 2025 | msn.comThe Goldman Sachs Group Has Lowered Expectations for NeoGenomics (NASDAQ:NEO) Stock PriceThe Goldman Sachs Group cut their target price on shares of NeoGenomics from $20.00 to $18.00 and set a "buy" rating on the stock in a report on Tuesday.January 28, 2025 | marketbeat.comStrong week for NeoGenomics (NASDAQ:NEO) shareholders doesn't alleviate pain of five-year lossJanuary 26, 2025 | finance.yahoo.comNEO Battery Materials to Establish Canada's First Silicon Anode Facility on 8 Acres in Windsor, OntarioJanuary 24, 2025 | globenewswire.comLeerink Partnrs Lowers Earnings Estimates for NeoGenomicsNeoGenomics, Inc. (NASDAQ:NEO - Free Report) - Leerink Partnrs reduced their Q1 2025 EPS estimates for shares of NeoGenomics in a research note issued on Tuesday, January 21st. Leerink Partnrs analyst P. Souda now expects that the medical research company will earn ($0.07) per share for the quartJanuary 23, 2025 | marketbeat.comNeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Rating of "Moderate Buy" by AnalystsShares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven analysts that are covering the firm, MarketBeat reports. Two research analysts have rated the stock with a hold recommendation and nine have given a buy recommeJanuary 19, 2025 | marketbeat.comNeoGenomics: Strong Revenue Growth and Strategic Initiatives Underpin Buy Rating Amidst Management ChangesJanuary 17, 2025 | markets.businessinsider.comBenchmark Co. Sticks to Its Hold Rating for NeoGenomics (NEO)January 16, 2025 | markets.businessinsider.comBenchmark retains Hold on Neogenomics stock, raises 2025 revenue forecastJanuary 16, 2025 | msn.comNeoGenomics: Balancing Promising Growth Prospects with Market Uncertainties and Valuation ConcernsJanuary 16, 2025 | markets.businessinsider.comFort Myers-based cancer lab expects strong performance in 2025, with new CEOJanuary 16, 2025 | msn.comNeoGenomics sees FY25 revenue $735M-$745M, consensus $727.9MJanuary 15, 2025 | markets.businessinsider.comNeoGenomics: Strong Financial Outlook and Strategic Growth Justify Buy RatingJanuary 15, 2025 | markets.businessinsider.comNeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial PlanJanuary 15, 2025 | finance.yahoo.comNeoGenomics rises on upbeat sales outlook for 2025January 15, 2025 | msn.comNeoGenomics Is On The Upswing, Reversing A CEO-Tied Sell-Off, On Bullish Long-Term GuidanceJanuary 15, 2025 | yahoo.comNeoGenomics (NASDAQ:NEO) Shares Gap Up - Time to Buy?NeoGenomics (NASDAQ:NEO) Shares Gap Up - Time to Buy?January 15, 2025 | marketbeat.comNeoGenomics management to meet with Piper SandlerJanuary 15, 2025 | markets.businessinsider.com Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address NEO Media Mentions By Week NEO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NEO News Sentiment▼-0.170.60▲Average Medical News Sentiment NEO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NEO Articles This Week▼264▲NEO Articles Average Week Get NeoGenomics News Delivered to You Automatically Sign up to receive the latest news and ratings for NEO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies WillScot Mobile Mini News Etsy News MARA News Lyft News QXO News Remitly Global News Amentum News Frontdoor News CarGurus News DLocal News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NEO) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeoGenomics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeoGenomics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NEO Stock Alerts